Quince Therapeutics, Inc. ( QNCX) - Stock Earnings
Stock symbol QNCX is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker QNCX was renamed to
IRLA
effective 2026-10-12.
QNCX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 11, 2026, midnight | — / — | — | — / — | — |
QNCX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -39.5 million USD | — USD |
| 2026Q1 | 35.9 million USD | — USD |
| 2026Q2 | -75.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
QNCX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.4 million USD | — USD |
| 2024 | -56.8 million USD | — USD |
| 2025 | -84.0 million USD | — USD |
| 2026 Est. | — | — |
QNCX
Price: $31.73
52 week price:
Earnings Per Share: -210.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 7.8 million